Literature DB >> 25733973

Pathologic processing of the total mesorectal excision.

Molly Campa-Thompson1, Robert Weir1, Natalie Calcetera2, Philip Quirke3, Susanne Carmack1.   

Abstract

Total mesorectal excision (TME) is the current optimal surgical treatment for patients with rectal carcinoma. A complete TME is related to lower local recurrence rates and increased patient survival. Many confounding factors in the patient's anatomy and prior therapy can make it difficult to obtain a perfect plane, and thus a complete TME. The resection specimen can be thoroughly evaluated, grossly and microscopically, to identify substandard surgical outcomes and increased risk of local recurrence. Complete and accurate data reporting is critical for patient care and helps surgeons improve their technique.

Entities:  

Keywords:  abdominoperineal resection; circumferential resection margin; rectal carcinoma; total mesorectal excision

Year:  2015        PMID: 25733973      PMCID: PMC4336908          DOI: 10.1055/s-0035-1545069

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  72 in total

1.  Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage.

Authors:  N S Goldstein; A Soman; J Sacksner
Journal:  Am J Clin Pathol       Date:  1999-03       Impact factor: 2.493

2.  Extent and completeness of mesorectal excision evaluated by postoperative magnetic resonance imaging.

Authors:  P Bondeven; R H Hagemann-Madsen; S Laurberg; B Ginnerup Pedersen
Journal:  Br J Surg       Date:  2013-09       Impact factor: 6.939

3.  The role of S100 staining in the pathological assessment of perineural invasion in rectal cancer.

Authors:  M White; A K Foulis; G Smith; P G Horgan; C S Roxburgh
Journal:  Colorectal Dis       Date:  2014-01       Impact factor: 3.788

4.  Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer.

Authors:  Jizhun Zhang; Liang Lv; Yingjiang Ye; Kewei Jiang; Zhanlong Shen; Shan Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-22       Impact factor: 4.553

5.  A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.

Authors:  Christian Wittekind; Carolyn Compton; Phil Quirke; Iris Nagtegaal; Susanne Merkel; Paul Hermanek; Leslie H Sobin
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

6.  Should quality measures for lymph node dissection in colon cancer be extrapolated to rectal cancer?

Authors:  Travis B Kidner; Junko J Ozao-Choy; Jeong Yoon; Anton J Bilchik
Journal:  Am J Surg       Date:  2012-09-13       Impact factor: 2.565

7.  Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis.

Authors:  Yen-Chien Lee; Chung-Cheng Hsieh; Jen-Pin Chuang
Journal:  Dis Colon Rectum       Date:  2013-09       Impact factor: 4.585

8.  Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.

Authors:  Marjun P Duldulao; Wendy Lee; Leanne Streja; Peiguo Chu; Wenyan Li; Zhenbin Chen; Joseph Kim; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2013-02       Impact factor: 4.585

9.  Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases.

Authors:  Seung Hyuk Baik; Nam Kyu Kim; Kang Young Lee; Seung Kook Sohn; Chang Hwan Cho; Myeong Jin Kim; Hogeun Kim; Rina K Shinn
Journal:  Ann Surg Oncol       Date:  2007-12-05       Impact factor: 5.344

10.  Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients.

Authors:  I Zlobec; M Hädrich; H Dawson; V H Koelzer; M Borner; M Mallaev; B Schnüriger; D Inderbitzin; A Lugli
Journal:  Br J Cancer       Date:  2013-12-24       Impact factor: 7.640

View more
  5 in total

1.  Oncological and quality of life outcomes following extralevator versus standard abdominoperineal excision for rectal cancer.

Authors:  D Kamali; A Sharpe; A Musbahi; A Reddy
Journal:  Ann R Coll Surg Engl       Date:  2017-05       Impact factor: 1.891

2.  Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.

Authors:  Julia Kitz; Emmanouil Fokas; Tim Beissbarth; Philipp Ströbel; Christian Wittekind; Arndt Hartmann; Josef Rüschoff; Thomas Papadopoulos; Elisabeth Rösler; Peter Ortloff-Kittredge; Ulrich Kania; Hans Schlitt; Karl-Heinrich Link; Wolf Bechstein; Hans-Rudolf Raab; Ludger Staib; Christoph-Thomas Germer; Torsten Liersch; Rolf Sauer; Claus Rödel; Michael Ghadimi; Werner Hohenberger
Journal:  JAMA Surg       Date:  2018-08-15       Impact factor: 14.766

3.  Uptake of Total Mesorectal Excision and Total Mesorectal Excision Grading for Rectal Cancer: A Statewide Study.

Authors:  Arielle E Kanters; Robert K Cleary; Shawn H Obi; Theodor Asgeirsson; Sarah K Evilsizer; Laurie G Fasbinder; Darrell A Campbell; Samantha K Hendren
Journal:  Dis Colon Rectum       Date:  2020-01       Impact factor: 4.412

4.  Outcomes of completion total mesorectal excision are not compromised by prior transanal minimally invasive surgery.

Authors:  S H E M Clermonts; T Köeter; H Pottel; L P S Stassen; D K Wasowicz; D D E Zimmerman
Journal:  Colorectal Dis       Date:  2020-02-04       Impact factor: 3.788

5.  Accurate surgical navigation with real-time tumor tracking in cancer surgery.

Authors:  Jasper Nijkamp; Theo J M Ruers; Esther N D Kok; Roeland Eppenga; Koert F D Kuhlmann; Harald C Groen; Ruben van Veen; Jolanda M van Dieren; Thomas R de Wijkerslooth; Monique van Leerdam; Doenja M J Lambregts; Wouter J Heerink; Nikie J Hoetjes; Oleksandra Ivashchenko; Geerard L Beets; Arend G J Aalbers
Journal:  NPJ Precis Oncol       Date:  2020-04-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.